Ушбу иш иқтибос қилган ишлар

186 та иш

Иш: Hypoxia‐Inducible Factors as Guardians of Cancer Stem Cell Fate: Implications for Novel Therapies

Cancer stem cells: advances in knowledge and implications for cancer therapy
Xianjing Chu, Wentao Tian, Jiaoyang Ning +7
Мақола20248 иқтибос
ABI
Prospective identification of tumorigenic breast cancer cells
Muhammad Al‐Hajj, Max S. Wicha, Adalberto Benito‐Hernández +2
Мақола20037 иқтибос
ABI
The role of regulatory T cells in the pathogenesis and treatment of prostate cancer
Vahid Karpisheh, Seyedeh Mahboubeh Mousavi, Parinaz Naghavi Sheykholeslami +6
Шарҳ мақола20216 иқтибос
ABI
Cancer stem cells: landscape, challenges and emerging therapeutic innovations
Haksoo Lee, Byeongsoo Kim, Junhyeong Park +7
Шарҳ мақола20256 иқтибос
ABI
Simultaneous blockade of TIGIT and HIF-1α induces synergistic anti-tumor effect and decreases the growth and development of cancer cells
Mehrdad Fathi, Simin Bahmanpour, Asal Barshidi +12
Мақола20215 иқтибос
ABI
Prostaglandin E2 as a potent therapeutic target for treatment of colon cancer
Vahid Karpisheh, Afshin Nikkhoo, Mohammad Hojjat‐Farsangi +7
Шарҳ мақола20195 иқтибос
ABI
EP4 receptor as a novel promising therapeutic target in colon cancer
Vahid Karpisheh, Navneet Joshi, Angelina Olegovna Zekiy +5
Шарҳ мақола20205 иқтибос
ABI
The role of Th17 cells in the pathogenesis and treatment of breast cancer
Vahid Karpisheh, Majid Ahmadi, Kazem Abbaszadeh‐Goudarzi +5
Шарҳ мақола20225 иқтибос
ABI
The sensitivity of acute myeloid leukemia cells to cytarabine is increased by suppressing the expression of Heme oxygenase-1 and hypoxia-inducible factor 1-alpha
Mohammad Reza Sadeghi, Asma Moslehi, Hadiseh Kheiry +11
Мақола20245 иқтибос
ABI
Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions
Zhou Chen, Fangfang Han, Yan Du +2
Шарҳ мақола20235 иқтибос
ABI
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
Karin E. de Visser, Johanna A. Joyce
Шарҳ мақола20235 иқтибос
ABI
Increased susceptibility to doxorubicin-induced cell death in acute lymphocytic leukemia cells by inhibiting serine/threonine WEE1 kinase expression using the chitosan-carboxymethyl dextran-polyethylene glycol-TAT nanoparticles
Abbas Ali Hosseinpour Feizi, Sajjad Vakili‐Samiani, Vahid Karpisheh +11
Мақола20224 иқтибос
ABI
Targeted Silencing of NRF2 by rituximab-conjugated nanoparticles increases the sensitivity of chronic lymphoblastic leukemia cells to Cyclophosphamide
Atefeh Khodakarami, Mahsa Afsari Kashani, Atefeh Nazer +13
Мақола20234 иқтибос
ABI
RETRACTED: Silencing STAT3 enhances sensitivity of cancer cells to doxorubicin and inhibits tumor progression
Navneet Joshi, Farnaz Hajizadeh, Ehsan Ansari Dezfouli +11
Мақола20214 иқтибос
ABI
Natural killer cell-derived exosomes for cancer immunotherapy: innovative therapeutics art
Zahra Hatami, Zahra Sadat Hashemi, Mohamad Eftekhary +4
Шарҳ мақола20234 иқтибос
ABI
The molecular biology and therapeutic potential of Nrf2 in leukemia
Atefeh Khodakarami, Sara Adibfar, Vahid Karpisheh +6
Шарҳ мақола20224 иқтибос
ABI
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice
Tsvee Lapidot, Christian Sirard, Josef Vormoor +7
Мақола19943 иқтибос
ABI
HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression
Brian Keith, Randall S. Johnson, M. Celeste Simon
Шарҳ мақола20113 иқтибос
ABI
Targeting HIF1α Eliminates Cancer Stem Cells in Hematological Malignancies
Yin Wang, Yan Liu, Sami N. Malek +2
Мақола20113 иқтибос
ABI
Anti‐angiogenic effects of CD73‐specific siRNA‐loaded nanoparticles in breast cancer‐bearing mice
Ghasem Ghalamfarsa, Ali Rastegari, Fatemeh Atyabi +11
Мақола20183 иқтибос
ABI
T‐cell immunoglobulin and ITIM domain, as a potential immune checkpoint target for immunotherapy of colorectal cancer
Mehrdad Fathi, Inna Pustokhina, Sergey V. Kuznetsov +5
Шарҳ мақола20213 иқтибос
ABI
Pan Cyclin-Dependent Kinase Inhibitors for the Treatment of Breast Cancer
Sepideh Izadi, Mohammad Hojjat Farsang, Vahid Karpisheh +1
Мақола20233 иқтибос
ABI
Advancing the therapeutic effectiveness of paclitaxel in chronic lymphocytic leukemia through the simultaneous inhibition of NOTCH1 and SF3B1
Shiva Abolhasani, Armin Mahmoud Salehi Khesht, Atefeh Khodakarami +13
Мақола20253 иқтибос
ABI
Cancer stem cells (CSCs) in cancer progression and therapy
Masoud Najafi, Bagher Farhood, Keywan Mortezaee
Шарҳ мақола20183 иқтибос
ABI
Everolimus (RAD001) sensitizes prostate cancer cells to docetaxel by down-regulation of HIF-1α and sphingosine kinase 1
Heba Alshaker, Qi Wang, Yoshiaki Kawano +5
Мақола20162 иқтибос
ABI